These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27781377)

  • 1. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.
    Mitchell SG; Bunting ST; Saxe D; Olson T; Keller FG
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
    Sotlar K; Fridrich C; Mall A; Jaussi R; Bültmann B; Valent P; Horny HP
    Leuk Res; 2002 Nov; 26(11):979-84. PubMed ID: 12363464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.
    Lee JW; Yang WS; Chung SY; Kang JH; Cho B; Kim HK; Kim KM; Jeong DC
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):412-5. PubMed ID: 17551405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian germ cell tumor/mastocytosis with KIT mutation: A unique clinicopathological entity.
    Xiao P; Chen P; Lang X; An Q; Yang C; Chen S; Wang K; Chen N; Hao Y; Ding J; Li Z; Hu S; Xiao S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):50-54. PubMed ID: 34553465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components.
    Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN
    Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone.
    Patnaik MM; Rangit Vallapureddy ; Lasho TL; Hoversten KP; Finke CM; Ketterling RP; Hanson CA; Gangat N; Tefferi A; Pardanani A
    Leukemia; 2018 Aug; 32(8):1850-1856. PubMed ID: 29712989
    [No Abstract]   [Full Text] [Related]  

  • 10. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.
    Tsutsumi M; Miura H; Inagaki H; Shinkai Y; Kato A; Kato T; Hamada-Tsutsumi S; Tanaka M; Kudo K; Yoshikawa T; Kurahashi H
    BMC Cancer; 2020 Nov; 20(1):1162. PubMed ID: 33246418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
    Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
    Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP; Sotlar K; Sperr WR; Valent P
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
    Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
    J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
    [No Abstract]   [Full Text] [Related]  

  • 15. Activating c-kit gene mutations in human germ cell tumors.
    Tian Q; Frierson HF; Krystal GW; Moskaluk CA
    Am J Pathol; 1999 Jun; 154(6):1643-7. PubMed ID: 10362788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).
    Valent P; Arock M; Akin C; Sperr WR; Reiter A; Sotlar K; Hartmann K; George TI; Brockow K; Kluin-Nelemans HC; Gotlib J; Metcalfe DD; Horny HP
    Blood; 2010 Aug; 116(5):850-1. PubMed ID: 20688965
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
    Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
    Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
    McClintock-Treep SA; Horny HP; Sotlar K; Foucar MK; Reichard KK
    J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.
    Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M
    Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
    Grifoni FI; Sciumè M; Pravettoni V; Ulivieri FM; Muratori S; Fracchiolla NS; Tagliaferri E; Gianelli U; Migliorini AC; Cro L; Pacilli A; Mannelli F; Baldini L
    Hematol Oncol; 2019 Apr; 37(2):205-211. PubMed ID: 30849188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.